The relationship between serum homocysteine levels and development of coronary collateral circulation in patients with acute coronary syndrome
Abstract
Aim:
Homocysteine is an amino acid that plays a role in folate metabolism and
inhibits endothelial cell proliferation which is important for angiogenesis. In
this study, we aimed to investigate the relationship between serum homocysteine
levels and coronary collateral development.
Material
and Method: 176
consecutive patients, with acute coronary syndrome and chronic total occlusion,
were divided into two groups according to coronary collateral development. Rentrop
0 and 1 were regarded as group I and Rentrop 2 and 3 as group II.
Results: Plasma homocysteine levels were 18,2 ± 7,0 μmol/L
in the group I and 15,7 ± 5,1 μmol/L in the group II. Univariate logistic regression analysis showed that mean
platelet volume and homocysteine were associated with poor coronary collateral.
Multivariate logistic regression analysis showed that homocysteine level was
independently associated with poor coronary collateral circulation (OR 1,069
[95% CI 1,012-1,130]; P=0,018).
Conclusion: In this study clearly demonstrates that high serum
homocysteine level is associated with poor collateral development in patients
with
acute coronary syndrome.
References
- 1. Cohen MV. The functional value of coronary collaterals in myocardial ischemia and therapeutic approach to enhance collateral flow. Am Heart J 1978;95:396-404.
- 2. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74:469–76.
- 3. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975–83.
- 4. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol.2009;132:257–62.
- 5. Seiler C. The human coronary collateral circulation. Eur J Clin Invest 2010;40:465–76.
- 6. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872–8.
- 7. Fowler B. Homocysteine an independent risk factor for cardiovascular and thrombotic diseases. Ther Umsch 2005;62:641-6.
- 8. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T, et al. Homocysteine inhibits angiogenesis in vivo and in vitro. Biochem Biophys Res Commun 2001; 281: 726– 731.
- 9. Rentrop Kp, Cohen M, Blanke H, Philips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587– 592.
Akut koroner sendromlu hastalarda serum homosistein düzeyleri ile koroner kollateral dolaşım gelişimi arasındaki ilişki
Abstract
Amaç:
Homosistein, folat metabolizmasında rol oynayan, anjiyogenez için önemli olan
endotelyal hücre proliferasyonunu inhibe eden bir aminoasittir. Bu çalışmada serum
homosistein düzeyiyle koroner kollateral gelişimi arasındaki ilişkiyi
araştırmayı amaçladık.
Gereç
ve Yöntem: 176 kronik total oklüzyonu olan hasta koroner
kollateral gelişimine göre 2 gruba ayrıldı. Rentrop 0 and 1 olanlar grup I
Rentrop 2 ve 3 olanlar grup II olarak kabul edildi.
Sonuç: Plazma
homosistein düzeyleri grup I'de 18,2 ± 7,0 μmol / L ve grup II'de 15,7 ± 5,1 μmol
/ L olarak saptandı. Tek değişkenli lojistik
regresyon analizi ortalama trombosit hacmi ve homosisteinin zayıf koroner kollateral
ile ilişkili olduğunu gösterdi. Çok değişkenli lojistik
regresyon analizi homosistein düzeyinin bağımsız olarak zayıf koroner
kollateral dolaşım ile ilişkili olduğunu göstermiştir (OR 1,069 [% 95 CI 1,012-1,130];P=0,018).
References
- 1. Cohen MV. The functional value of coronary collaterals in myocardial ischemia and therapeutic approach to enhance collateral flow. Am Heart J 1978;95:396-404.
- 2. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74:469–76.
- 3. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975–83.
- 4. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol.2009;132:257–62.
- 5. Seiler C. The human coronary collateral circulation. Eur J Clin Invest 2010;40:465–76.
- 6. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872–8.
- 7. Fowler B. Homocysteine an independent risk factor for cardiovascular and thrombotic diseases. Ther Umsch 2005;62:641-6.
- 8. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T, et al. Homocysteine inhibits angiogenesis in vivo and in vitro. Biochem Biophys Res Commun 2001; 281: 726– 731.
- 9. Rentrop Kp, Cohen M, Blanke H, Philips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587– 592.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | March 19, 2020 |
| Published in Issue | Year 2020 Volume: 3 Issue: 2 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.